6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)
Date du début: 1 oct. 2013, Date de fin: 31 mars 2020,
Traumatic Brain Injury (TBI) is a major cause of death and disability, leading to great personal suffering to victim and relatives, as well as huge direct and indirect costs to society. Strong ethical, medical, social and health economic reasons therefore exist for improving treatment. The CENTER-TBI project will collect a prospective, contemporary, highly granular, observational dataset of 5400 p ...
Voir le projet
44
Participants partenaires
TERMINÉ
Autologous Stem Cell Seeded Tissue Engineered Trachea (TETRA)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
...the limitations of standard clinical care and competitor products under development and will:- Build on our successful compassionate use experience using autologous stem cell seeded scaffold-tracheal transplants in 48 patients- Follow on from our Phase I 4 patient INSPIRE clinical trial which will improve on the clinical prototype used in compassionate use cases- Conduct a 48 patient Phase II pivo ...
Voir le projet
14
Participants partenaires
TERMINÉ
Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2019,
...hich is already the most common cause of chronic kidney disease. DKD is associated with greatly increased mortality and frequently progresses to end stage renal failure. Pharmacotherapy, dialysis and transplantation represent the mainstay treatments for DKD but are costly and provide only limited protection against adverse outcomes. Mesenchymal Stromal Cell (MSC) therapy is a promising approach to ...
Voir le projet
12
Participants partenaires
TERMINÉ
MEsenchymal stem cells to Reduce Liver INflammation (MERLIN)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2018,
"Prevalence of liver disease is c6% (29 million people) in the EU with mortality rates from chronic liver diseases estimated at 14.3 per 100.000 in the EU-25 in 2004. Most liver diseases have a significant inflammatory component that underpins liver damage and fibrogenesis, yet current therapies have limited effectiveness. Safe novel anti-inflammatory therapies would satisfy a large unmet need for ...
Voir le projet
9
Participants partenaires
TERMINÉ
A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches (EUROSTAM)
Date du début: 1 déc. 2012, Date de fin: 30 nov. 2015,
The presence of donor specific HLA antibodies is a contra-indication for renal transplantation. Highly sensitized patients accumulate and often die on the transplant waiting lists as it is almost impossible to find donors towards which they don’t have antibodies. The acceptable mismatch program of Eurotransplant has shown to be an effective tool to enhance successful transplantation of highly sens ...
Voir le projet
11
Participants partenaires
TERMINÉ
Networking of materials laboratories and innovation actors in various industrial sectors for product or process innovation (InnoMatNet)
Date du début: 1 avr. 2012, Date de fin: 30 sept. 2014,
...TNs mentioned as well as the European Business Innovation Centre Network (EBN), in particular creative industries and product designers are included through the European Architecture Foundation, EBN, Transplant (design) and the Materials KTN (has a network of 2000 product designers). Expertise in innovation support (particularly open innovation) and other diverse relevant areas such as metrology, ...
Voir le projet